D-dimer predicts postoperative recurrence and prognosis in patients with liver metastasis of colorectal cancer

[1]  B. Naume,et al.  Survival Impact of Primary Tumor Lymph Node Status and Circulating Tumor Cells in Patients with Colorectal Liver Metastases , 2017, Annals of Surgical Oncology.

[2]  Y. Dong,et al.  Expression and clinical relevance of epithelial and mesenchymal markers in circulating tumor cells from colorectal cancer , 2016, Oncotarget.

[3]  C. Kirwan,et al.  PO-31 - Circulating tumour cells and hypercoagulability: a lethal relationship in metastatic breast cancer. , 2016, Thrombosis research.

[4]  H. Versteeg,et al.  Anticoagulants versus cancer. , 2016, Thrombosis research.

[5]  H. Lenz,et al.  Primary tumor location as a prognostic factor in metastatic colorectal cancer. , 2015, Journal of the National Cancer Institute.

[6]  Jung Hun Kang,et al.  D-Dimer Can Serve as a Prognostic and Predictive Biomarker for Metastatic Gastric Cancer Treated by Chemotherapy , 2015, Medicine.

[7]  X. Fang,et al.  Different treatment strategies and molecular features between right-sided and left-sided colon cancers. , 2015, World journal of gastroenterology.

[8]  Y. Sakamoto,et al.  Post-chemotherapeutic CEA and CA19-9 are prognostic factors in patients with colorectal liver metastases treated with hepatic resection after oxaliplatin-based chemotherapy. , 2015, Anticancer research.

[9]  H. Zhong,et al.  High levels of D-dimer correlated with disease status and poor prognosis of inoperable metastatic colorectal cancer patients treated with bevacizumab. , 2014, Journal of cancer research and therapeutics.

[10]  Murali Krishna Gurram,et al.  Effectiveness of D-Dimer as a Screening Test for Venous Thromboembolism: An Update , 2014, North American journal of medical sciences.

[11]  O. Thorlacius-Ussing,et al.  Prognostic value of preoperative d-dimer and carcinoembryonic antigen levels in patients undergoing intended curative resection for colorectal cancer: a prospective cohort study , 2014, International Journal of Colorectal Disease.

[12]  M. Tez,et al.  Role of surgery in colorectal cancer liver metastases. , 2014, World journal of gastroenterology.

[13]  Yanyan Li,et al.  Prognostic role of D-dimer in patients with lung cancer: a meta-analysis , 2014, Tumor Biology.

[14]  R. Parks,et al.  Surgery for Colorectal Liver Metastases , 2013, Digestive Surgery.

[15]  Mingxia Yu,et al.  Predictive value of serum CEA, CA19-9 and CA125 in diagnosis of colorectal liver metastasis in Chinese population. , 2013, Hepato-gastroenterology.

[16]  Zhong-min Yang,et al.  High plasma D-dimer level is associated with decreased survival in patients with lung cancer: a meta-analysis , 2013, Tumor Biology.

[17]  O. Er,et al.  D-dimer is a marker of response to chemotherapy in patients with metastatic colorectal cancer. , 2013, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[18]  Y. Kanda,et al.  Investigation of the freely available easy-to-use software ‘EZR' for medical statistics , 2012, Bone Marrow Transplantation.

[19]  S. Tsutsui,et al.  Plasma D-Dimer Level as a Mortality Predictor in Patients with Advanced or Recurrent Colorectal Cancer , 2012, Oncology.

[20]  G. Honda,et al.  A nomogram predicting disease-free survival in patients with colorectal liver metastases treated with hepatic resection: multicenter data collection as a Project Study for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery , 2012, Journal of hepato-biliary-pancreatic sciences.

[21]  M. Prins,et al.  Randomized trial of the effect of the low molecular weight heparin nadroparin on survival in patients with cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  L. Fink,et al.  Increases in quantitative D-dimer levels correlate with progressive disease better than circulating tumor cell counts in patients with refractory prostate cancer. , 2010, American journal of clinical pathology.

[23]  A. Algra,et al.  Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials , 2010, The Lancet.

[24]  K. Kaneko,et al.  Therapeutic significance of a D-dimer cut-off level of >3 µg/ml in colorectal cancer patients treated with standard chemotherapy plus bevacizumab. , 2010, Japanese journal of clinical oncology.

[25]  M. Yano,et al.  Correlation between pretherapeutic d-dimer levels and response to neoadjuvant chemotherapy in patients with advanced esophageal cancer. , 2008, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[26]  T. Ertan,et al.  Prognostic value of plasma D‐dimer levels in patients with colorectal cancer , 2008, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[27]  T. Takada,et al.  Proposal of criteria to select candidates with colorectal liver metastases for hepatic resection: comparison of our scoring system to the positive number of risk factors. , 2006, World journal of gastroenterology.

[28]  O. Garden,et al.  Surgical resection of hepatic metastases from colorectal cancer: A systematic review of published studies , 2006, British Journal of Cancer.

[29]  Susanne M. Smorenburg,et al.  The effect of low molecular weight heparin on survival in patients with advanced malignancy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  M. Dewhirst,et al.  Circulating D‐dimer levels are better predictors of overall survival and disease progression than carcinoembryonic antigen levels in patients with metastatic colorectal carcinoma , 2004, Cancer.

[31]  G. Lip,et al.  Platelet activation, coagulation and angiogenesis in breast and prostate carcinoma , 2004, Thrombosis and Haemostasis.

[32]  Ya-li Zhang,et al.  Relationship between plasma D-dimer levels and clinicopathologic parameters in resectable colorectal cancer patients. , 2004, World journal of gastroenterology.

[33]  L H Blumgart,et al.  Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. , 1999, Annals of surgery.

[34]  C. Edwards,et al.  D‐dimer: A useful marker of disease stage in surgery for colorectal cancer , 1993, The British journal of surgery.

[35]  V A Memoli,et al.  Pathways of Coagulation/Fibrinolysis Activation in Malignancy , 1992, Seminars in thrombosis and hemostasis.

[36]  J. Staško,et al.  D-dimer, plasminogen activator inhibitor-1, prothrombin fragments and protein C - role in prothrombotic state of colorectal cancer. , 2011, Neoplasma.

[37]  M. Oya,et al.  Plasma D-dimer level in patients with colorectal cancer: Its role as a tumor marker , 2010, Surgery Today.

[38]  P. Vermeulen,et al.  Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients. , 1997, British Journal of Cancer.